Several investment funds related to Medical Resources chairman Gary Siegler have accumulated a large stock position in independent service organization COHR, according to documents on file with the Securities and Exchange Commission. As of Dec. 31,
Several investment funds related to Medical Resources chairman Gary Siegler have accumulated a large stock position in independent service organization COHR, according to documents on file with the Securities and Exchange Commission. As of Dec. 31, Siegler, a business partner, and firms related to the two owned a total of 33% of Chatsworth, CA-based COHR.
Siegler runs several investment funds that often acquire positions in medical imaging companies like Medical Resources, in which Siegler invested in 1990. Siegler's activities at Medical Resources are at the center of a controversy that erupted in November, when a number of executives left the imaging services firm in a dispute over what they said were improper advisory fees paid to one of Siegler's companies (SCAN 12/17/97).
According to the SEC documents filed Jan. 7, Siegler and his business partner, Peter Collery, have also been building a large position in COHR. As of Dec. 31, Siegler and Collery each held 9.3% of COHR common stock, while investment funds controlled by them, including SC Fundamental, SC Fundamental Value Fund, and SC Fundamental Value BVI, hold a further 14.4%, for a total position of 33%. The SEC documents, called 13D filings, must be submitted whenever an investor acquires more than 5% of a registered security, according to the SEC.
COHR has undergone some turmoil in recent months. Chairman and CEO Paul Chopra, who led the company on an aggressive acquisition drive, left the ISO last year after the company reported disappointing second-quarter earnings. COHR announced in December that it had retained Lehman Brothers to help it explore strategic alternatives that might include the sale of the company (SCAN 1/14/98).
A spokesperson for COHR said the company would be unable to comment on how much of COHR the Siegler-related firms own until the company receives SEC documentation in mid-February. Siegler declined to comment on the investments as of press time.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
2 Commerce Drive
Cranbury, NJ 08512